HDL-associated MPO was negatively correlated with PON1 activity in patients with type 2 diabetes and coexisting CVD, non-diabetic patients with chronic ischemic heart disease, and patients with acute coronary syndromes [48]; the results similar to that observed by us in RA patients. This evidence concerns the gene PON1 and acute coronary syndrome.